PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-24.62%
Both yoy net incomes decline, with META at -26.96%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-7.10%
Negative yoy D&A while META is 5.54%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-81.98%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
1.35%
SBC growth while META is negative at -17.87%. John Neff would see competitor possibly controlling share issuance more tightly.
277.78%
Well above META's 219.25% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
160.64%
AR growth well above META's 124.28%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-251.69%
Negative yoy inventory while META is 82.24%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-104.37%
Both negative yoy AP, with META at -178.95%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
386.83%
Growth well above META's 62.28%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
96.89%
Lower 'other non-cash' growth vs. META's 300.00%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
3.98%
Operating cash flow growth at 50-75% of META's 7.39%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
17.57%
CapEx growth well above META's 2.90%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-149.23%
Negative yoy acquisition while META stands at 93.91%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
1.64%
Some yoy expansion while META is negative at -5.75%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-28.82%
Both yoy lines are negative, with META at -24.00%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-78.91%
We reduce yoy other investing while META is 109.79%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-125.36%
We reduce yoy invests while META stands at 57.01%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-34.36%
Both yoy lines negative, with META at -6.82%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.